Your browser doesn't support javascript.
loading
Reply to: Comments on: Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein.
Kotchetkov, Rouslan; Susman, David; Bhutani, Divaya; Broch, Kaspar; Dispenzieri, Angela; Buadi, Francis K.
Afiliação
  • Kotchetkov R; Simcoe Muskoka Regional Cancer Program, Royal Victoria Regional Health Centre, Barrie, Ontario, Canada.
  • Susman D; Western University, London, Ontario, Canada.
  • Bhutani D; Division of Hematology and Oncology, Columbia University Medical Center, Multiple Myeloma and Amyloidosis Program, New York, New York, USA.
  • Broch K; Department of Cardiology, Oslo University Hospital, Oslo, Norway.
  • Dispenzieri A; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Buadi FK; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
Int J Cancer ; 149(3): 743-744, 2021 08 01.
Article em En | MEDLINE | ID: mdl-33742687
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Miopatias da Nemalina Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Miopatias da Nemalina Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article